by EmVenio | May 19, 2025 | Blog
This April, the EmVenio and PCM Trials team traveled to Washington, D.C., for the 2025 World Vaccine Congress. In addition to attending informative panels, lectures and sessions on everything from research to commercial manufacturing of vaccines, our team hosted a...
by EmVenio | May 12, 2025 | Press Release
DENVER, Colo., May 12, 2025 – Clinical trials organization EmVenio Research was named winner for Best Clinical Trial Company at the 2025 Vaccine Industry Excellence Awards. The award ceremony was held April 22 during the 2025 World Vaccine Congress in Washington, D.C....
by EmVenio | Apr 11, 2025 | Blog
In the summer of 2024, EmVenio launched brick-and-mortar clinical trial research centers on select Prime hospital campuses. Like our mobile community research sites, these locations were strategically chosen using social determinants of health of the surrounding...
by EmVenio | Feb 17, 2025 | Blog
This February, EmVenio team members, along with our parent company PCM Trials, attended the 16th annual SCOPE Summit in Orlando, Florida. We were excited to see familiar and new faces and share more about our innovations and success in clinical research. At the...
by EmVenio | Nov 18, 2024 | Webinar
The clinical research industry continues to evolve, with efficiency and precision taking center stage in study start-up processes. A recent webinar, Efficient Study Start-Up: Best Practices from a Clinical Site Network, presented by Xtalks, explored the intricacies of...
